Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis
- 28 November 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 21 (3) , 289-304
Abstract
Confusion regarding methadone metabolism exists, hampering optimal clinical use. A systematic review was conducted to assess the impacts of cytochrome P450 (CYP) genetic polymorphisms on methadone outcomes. MEDLINE, EMBASE, Web of Science, PsycINFO, and CENTRAL were searched to identify studies reporting methadone dose-adjusted plasma concentrations, clearance, maintenance dose, or treatment response in relation to CYP polymorphisms in humans. ROBINS-I was used to evaluate risk of bias in included studies. Each outcome was synthesized for each CYP using the ratio of means or odds ratio as the effect size measure. Ten, two, fourteen, and five studies were included in the meta-analyses of the concentration, clearance, dose, and treatment response, respectively. The CYP2B6 c.516 G>T variant was robustly associated with (S)-methadone concentrations (GT+TTvs.GG: ratio of means (RoM) 1.40, p < 0.01) and clearance (GT+TTvs.GG: RoM 0.65, p < 0.01) but less with (R)- or (R,S)-methadone. The CYP2B6 variant also affected methadone dose for opioid use disorder (GT+TTvs.GG: RoM 0.93, p = 0.04). CYP2C19, CYP2C9, CYP2D6, and CYP3A5 polymorphisms did not influence any of the assessed outcomes. CYP2B6 genetics had statistically significant impacts on (S)-methadone and less so on (R)-methadone exposure and clearance and was statistically significantly but not clinically meaningfully associated with dose requirements.Keywords
Funding Information
- National Institutes of Health (R01-DA042985)
This publication has 50 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone TherapyClinical Pharmacology & Therapeutics, 2024
- Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal DetectionClinical Pharmacology & Therapeutics, 2022
- PharmVar GeneFocus: CYP2B6Clinical Pharmacology & Therapeutics, 2021
- Methadone Disposition: Implementing Lessons LearnedThe Journal of Clinical Pharmacology, 2019
- Worldwide Distribution of Cytochrome P450 Alleles: A Meta‐analysis of Population‐scale Sequencing ProjectsClinical Pharmacology & Therapeutics, 2017
- Current Concepts in Methadone Metabolism and TransportClinical Pharmacology in Drug Development, 2017
- Drug interactions with methadone: Time to revise the product labelClinical Pharmacology in Drug Development, 2014
- Role of Cytochrome P4502B6 in Methadone Metabolism and ClearanceThe Journal of Clinical Pharmacology, 2013
- Substitution of (R,S)-Methadone by (R)-MethadoneArchives of internal medicine (1960), 2010
- Stereoselective metabolism of methadone N‐demethylation by cytochrome P4502B6 and 2C19Chirality, 2003